Alta-innovations news

NewsRSS FeedAtom Feed

University of Birmingham Spinout Company is developing a novel drug for the treatment of Glaucoma

Description
Scientists at the University of Birmingham have received funding from the Technology Strategy Board, the UK's innovation agency, to develop a novel multi action siRNA drug with proven neuroprotective and neuroregenerative activity to treat Glaucoma.
Date:
20/03/2013

PsiOxus Therapeutics Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-102

Description
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Date:
04/03/2013

University of Birmingham scientists devise unique stroke assessment tool

Description
Scientists at the University of Birmingham have devised a unique screening instrument that provides a 'one-stop' brain function profile of patients who have suffered stroke or other neurological damage.
Date:
16/01/2013

University of Birmingham medical spinout company wins award

Description
Serascience Limited, a specialist cancer diagnostic company has been awarded best start-up at the 2012 Medilink West Midlands Healthcare Business Awards (6th December).The awards celebrate the very best and most promising new healthcare businesses in the region.
Date:
10/12/2012

Smart Antenna Team recognised for pioneering compact antenna design

Description
A team from the School of Electronic, Electrical and Computer Engineering at the University of Birmingham recently celebrated a win at the finals of the national Discovering Start-Ups competition (21st November).
Date:
27/11/2012

Alta Bioscience wins £100,000 grant from Birmingham Post Business Growth Fund

Description
Alta Bioscience Ltd, a specialist contract manufacturing and analysis organization, is pleased to announce that it has won funding of £100,000 in the form of a grant from the Birmingham Post Business Growth Fund, which will be used to expand the Company's current successful offering of the analysis of amino-acids for the food industry, pharmaceutical industry and academia.
Date:
17/09/2012
Displaying 31 to 40 of 45